Privium Fund Management (UK)’s Merck MRK Stock Holding History

Privium Fund Management (UK)’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-24,072	Closed	-$3.07M	–	100
2024 Q2	$3.07M	Buy	+24,072	New	+$3.1M	1.2%	12

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Privium Fund Management (UK)'s MRK Position: Q3 2024 in Review

Privium Fund Management (UK) sold out of Merck (MRK) in Q3 2024, closing a stake of 24,072 shares — an estimated $3.07M sold.

Privium Fund Management (UK) first reported a position in MRK in Q2 2024 and held it in 1 quarter. The position peaked at $3.07M in Q2 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

Privium Fund Management (UK) reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
Privium Fund Management (UK) sold 24,072 Merck shares in Q3 2024, an estimated $3.07M.
Privium Fund Management (UK) first reported a position in Merck in Q2 2024 and held it in 1 quarter.
Privium Fund Management (UK)'s Merck position peaked at $3.07M in Q2 2024.
3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Privium Fund Management (UK)'s 13F filing for Q3 2024, filed 5 Nov 2024.